These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 38423796)
1. The role of β-adrenergic receptors in the regulation of cardiac tolerance to ischemia/reperfusion. Why do β-adrenergic receptor agonists and antagonists protect the heart? Maslov LN; Naryzhnaya NV; Voronkov NS; Kurbatov BK; Derkachev IA; Ryabov VV; Vyshlov EV; Kolpakov VV; Tomilova EA; Sapozhenkova EV; Singh N; Fu F; Pei J Fundam Clin Pharmacol; 2024 Aug; 38(4):658-673. PubMed ID: 38423796 [TBL] [Abstract][Full Text] [Related]
2. The role of β-adrenergic receptors in the cardioprotective effects of beta-preconditioning (βPC). Salie R; Moolman JA; Lochner A Cardiovasc Drugs Ther; 2011 Feb; 25(1):31-46. PubMed ID: 21225332 [TBL] [Abstract][Full Text] [Related]
3. Cardioprotective and survival benefits of long-term combined therapy with beta2 adrenoreceptor (AR) agonist and beta1 AR blocker in dilated cardiomyopathy postmyocardial infarction. Ahmet I; Krawczyk M; Zhu W; Woo AY; Morrell C; Poosala S; Xiao RP; Lakatta EG; Talan MI J Pharmacol Exp Ther; 2008 May; 325(2):491-9. PubMed ID: 18287209 [TBL] [Abstract][Full Text] [Related]
4. Adrenergic signaling in heart failure: a balance of toxic and protective effects. Baker AJ Pflugers Arch; 2014 Jun; 466(6):1139-50. PubMed ID: 24623099 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic synergy and complementarity for ischemia/reperfusion injury: β1-adrenergic blockade and phosphodiesterase-3 inhibition. Huang MH; Poh KK; Tan HC; Welt FG; Lui CY Int J Cardiol; 2016 Jul; 214():374-80. PubMed ID: 27085132 [TBL] [Abstract][Full Text] [Related]
6. Cardioprotective Effects of Beta3-Adrenergic Receptor (β3-AR) Pre-, Per-, and Post-treatment in Ischemia-Reperfusion. Salie R; Alsalhin AKH; Marais E; Lochner A Cardiovasc Drugs Ther; 2019 Apr; 33(2):163-177. PubMed ID: 30729348 [TBL] [Abstract][Full Text] [Related]
7. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors. Baker JG Br J Pharmacol; 2005 Feb; 144(3):317-22. PubMed ID: 15655528 [TBL] [Abstract][Full Text] [Related]
8. Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells. Carpéné C; Galitzky J; Fontana E; Atgié C; Lafontan M; Berlan M Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):310-21. PubMed ID: 10344530 [TBL] [Abstract][Full Text] [Related]
9. β-Blockers promote angiogenesis in the mouse aortic ring assay. Stati T; Musumeci M; Maccari S; Massimi A; Corritore E; Strimpakos G; Pelosi E; Catalano L; Marano G J Cardiovasc Pharmacol; 2014 Jul; 64(1):21-7. PubMed ID: 24621648 [TBL] [Abstract][Full Text] [Related]
11. β3 adrenergic receptor selective stimulation during ischemia/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes. García-Prieto J; García-Ruiz JM; Sanz-Rosa D; Pun A; García-Alvarez A; Davidson SM; Fernández-Friera L; Nuno-Ayala M; Fernández-Jiménez R; Bernal JA; Izquierdo-Garcia JL; Jimenez-Borreguero J; Pizarro G; Ruiz-Cabello J; Macaya C; Fuster V; Yellon DM; Ibanez B Basic Res Cardiol; 2014 Jul; 109(4):422. PubMed ID: 24951958 [TBL] [Abstract][Full Text] [Related]
12. Effects of β-adrenergic receptor drugs on embryonic ventricular cell proliferation and differentiation and their impact on donor cell transplantation. Feridooni T; Hotchkiss A; Baguma-Nibasheka M; Zhang F; Allen B; Chinni S; Pasumarthi KBS Am J Physiol Heart Circ Physiol; 2017 May; 312(5):H919-H931. PubMed ID: 28283550 [TBL] [Abstract][Full Text] [Related]
13. Roles of kappa opioid receptors in cardioprotection against ischemia: the signaling mechanisms. Wong TM; Wu S Sheng Li Xue Bao; 2003 Apr; 55(2):115-20. PubMed ID: 12715097 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological modulation of b-adrenoceptors as a new cardioprotective strategy for therapy of myocardial dysfunction induced by ischemia and reperfusion. Menezes-Rodrigues FS; Errante PR; Tavares JGP; Ferraz RRN; Gomes WJ; Taha MO; Scorza CA; Scorza FA; Caricati-Neto A Acta Cir Bras; 2019; 34(5):e201900505. PubMed ID: 31166461 [TBL] [Abstract][Full Text] [Related]
15. Regulation of cyclic adenosine monophosphate release by selective β2-adrenergic receptor stimulation in human terminal failing myocardium before and after ventricular assist device support. Kassner A; Toischer K; Bohms B; Kolkhof P; Abraham G; Hasenfuβ G; Morshuis M; Schulte Eistrup S; El-Banayosy A; Gummert J; Milting H J Heart Lung Transplant; 2012 Oct; 31(10):1127-35. PubMed ID: 22975104 [TBL] [Abstract][Full Text] [Related]
16. An increase in murine skeletal muscle peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) mRNA in response to exercise is mediated by beta-adrenergic receptor activation. Miura S; Kawanaka K; Kai Y; Tamura M; Goto M; Shiuchi T; Minokoshi Y; Ezaki O Endocrinology; 2007 Jul; 148(7):3441-8. PubMed ID: 17446185 [TBL] [Abstract][Full Text] [Related]
17. Do platelets protect the heart against ischemia/reperfusion injury or exacerbate cardiac ischemia/reperfusion injury? The role of PDGF, VEGF, and PAF. Voronkov NS; Maslov LN; Vyshlov EV; Mukhomedzyanov AV; Ryabov VV; Derkachev IA; Kan A; Gusakova SV; Gombozhapova AE; Panteleev OO Life Sci; 2024 Jun; 347():122617. PubMed ID: 38608835 [TBL] [Abstract][Full Text] [Related]